首页 | 官方网站   微博 | 高级检索  
     

注射用重组改构人肿瘤坏死因子治疗恶性胸腔积液临床观察
引用本文:汪舸,闵海燕,张航. 注射用重组改构人肿瘤坏死因子治疗恶性胸腔积液临床观察[J]. 现代肿瘤医学, 2011, 19(10): 2029-2030. DOI: 10.3969/j.issn.1672-4992.2011.10.39
作者姓名:汪舸  闵海燕  张航
作者单位:南京医科大学附属常州市第二人民医院肿瘤科,江苏,常州,213002
摘    要:目的:探讨注射用重组改构人肿瘤坏死因子(recombinant metant human tumor necrossis factor,rmhT-NF)和顺铂(cisplatin,DDP)治疗恶性胸水的疗效和不良反应。方法:将60例恶性胸水患者随机分为rmhTNF组和DDP组,观察各组的疗效、起效时间和副反应。结果:TNF组总有效率86.7%,DDP组总有效率66.7%,TNF组效果好于DDP组,P<0.05,有统计学意义。结论:使用rmhTNF治疗恶性胸水起效较快,疗效确切,较顺铂治疗副反应小,操作简便,有临床应用价值。

关 键 词:恶性胸腔积液  注射用重组改构人肿瘤坏死因子  顺铂

A clinical observation of malignant pleural effusion treated by intrapleural perfusion with recombinant mutant human tumor necrosis factor
WANG Ge,MIN Haiyan,ZHANG Hang. A clinical observation of malignant pleural effusion treated by intrapleural perfusion with recombinant mutant human tumor necrosis factor[J]. Journal of Modern Oncology, 2011, 19(10): 2029-2030. DOI: 10.3969/j.issn.1672-4992.2011.10.39
Authors:WANG Ge  MIN Haiyan  ZHANG Hang
Affiliation:WANG Ge,MIN Haiyan,ZHANG Hang Department of Oncology,the Affiliated Hospital of Nanjing Medical University,Jiangsu Changzhou 213002,China.
Abstract:Objective:To approach the clinical effect and adverse reaction of recombinant metant human tumor necrossis factor(rmhTNF) and DDP in the treatment of malignant pleural effusion.Methods: Sixty patients with maligant pleural effusion were randomly devided into two groups:groupTNF was infused with rmhTNF,the another one was infused with DDP.The effective rate,responding time and adverse reaction were observed.Results: The total effective rate of rmhTNF group was 86.7%,while it was 66.7% in groupDDP.There was a...
Keywords:malignant pleural effusion  rmhTNF  DDP  
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号